Article: Sodium/myo-inositol cotransporter 1 and myo-inositol are essential for osteogenesis and bone formation

File Download Links for fulltext
(May Require Subscription)
Supplementary
  • Basic View
  • Metadata View
  • XML View
TitleSodium/myo-inositol cotransporter 1 and myo-inositol are essential for osteogenesis and bone formation
AuthorsDai, Z
Chung, SK
Miao, D2
Lau, KS
Chan, AWH1
Kung, AWC
Keywordsbone formation
myo-inositol
osteogenesis
Smit1
Issue Date2011
PublisherAmerican Society for Bone and Mineral Research. The Journal's web site is located at http://www.jbmr.org/view/0/index.html
CitationJournal Of Bone And Mineral Research, 2011, v. 26 n. 3, p. 582-590 [How to Cite?]
DOI: http://dx.doi.org/10.1002/jbmr.240
Abstractmyo-Inositol (MI) plays an essential role in several important processes of cell physiology, is involved in the neural system, and provides an effective treatment for some psychiatric disorders. Its role in osteogenesis and bone formation nonetheless is unclear. Sodium/MI cotransporter 1 (SMIT1, the major cotransporter of MI) knockout (SMIT1 -/-) mice with markedly reduced tissue MI levels were used to characterize the essential roles of MI and SMIT1 in osteogenesis. SMIT1 -/- embryos had a dramatic delay in prenatal mineralization and died soon after birth owing to respiratory failure, but this could be rescued by maternal MI supplementation. The rescued SMIT1 -/- mice had shorter limbs, decreased bone density, and abnormal bone architecture in adulthood. Deletion of SMIT1 resulted in retarded postnatal osteoblastic differentiation and bone formation in vivo and in vitro. Continuous MI supplementation partially restored the abnormal bone phenotypes in adult SMIT1 -/- mice and strengthened bone structure in SMIT1 +/+ mice. Although MI content was much lower in SMIT1 -/- mesenchymal cells (MSCs), the I(1,4,5)P 3 signaling pathway was excluded as the means by which SMIT1 and MI affected osteogenesis. PCR expression array revealed Fgf4, leptin, Sele, Selp, and Nos2 as novel target genes of SMIT1 and MI. SMIT1 was constitutively expressed in multipotential C3H10T1/2 and preosteoblastic MC3T3-E1 cells and could be upregulated during bone morphogenetic protein 2 (BMP-2)-induced osteogenesis. Collectively, this study demonstrated that deficiency in SMIT1 and MI has a detrimental impact on prenatal skeletal development and postnatal bone remodeling and confirmed their essential roles in osteogenesis, bone formation, and bone mineral density (BMD) determination. © 2011 American Society for Bone and Mineral Research. Copyright © 2011 American Society for Bone and Mineral Research.
ISSN0884-0431
2011 Impact Factor: 6.373
2011 SCImago Journal Rankings: 0.622
DOIhttp://dx.doi.org/10.1002/jbmr.240
ISI Accession Number IDWOS:000287827600019
Funding AgencyGrant Number
KC Wong Education Foundation
Osteoporosis and Endocrine Research, the University of Hong Kong
Funding Information:

ZD was supported by the KC Wong Education Foundation. This project was supported by the Osteoporosis and Endocrine Research, the University of Hong Kong.

ReferencesReferences in Scopus
DC Field
Value
dc.contributor.authorDai, Z
dc.contributor.authorChung, SK
dc.contributor.authorMiao, D
dc.contributor.authorLau, KS
dc.contributor.authorChan, AWH
dc.contributor.authorKung, AWC
dc.date.accessioned2011-05-11T08:30:38Z
dc.date.available2011-05-11T08:30:38Z
dc.date.issued2011
dc.description.abstractmyo-Inositol (MI) plays an essential role in several important processes of cell physiology, is involved in the neural system, and provides an effective treatment for some psychiatric disorders. Its role in osteogenesis and bone formation nonetheless is unclear. Sodium/MI cotransporter 1 (SMIT1, the major cotransporter of MI) knockout (SMIT1 -/-) mice with markedly reduced tissue MI levels were used to characterize the essential roles of MI and SMIT1 in osteogenesis. SMIT1 -/- embryos had a dramatic delay in prenatal mineralization and died soon after birth owing to respiratory failure, but this could be rescued by maternal MI supplementation. The rescued SMIT1 -/- mice had shorter limbs, decreased bone density, and abnormal bone architecture in adulthood. Deletion of SMIT1 resulted in retarded postnatal osteoblastic differentiation and bone formation in vivo and in vitro. Continuous MI supplementation partially restored the abnormal bone phenotypes in adult SMIT1 -/- mice and strengthened bone structure in SMIT1 +/+ mice. Although MI content was much lower in SMIT1 -/- mesenchymal cells (MSCs), the I(1,4,5)P 3 signaling pathway was excluded as the means by which SMIT1 and MI affected osteogenesis. PCR expression array revealed Fgf4, leptin, Sele, Selp, and Nos2 as novel target genes of SMIT1 and MI. SMIT1 was constitutively expressed in multipotential C3H10T1/2 and preosteoblastic MC3T3-E1 cells and could be upregulated during bone morphogenetic protein 2 (BMP-2)-induced osteogenesis. Collectively, this study demonstrated that deficiency in SMIT1 and MI has a detrimental impact on prenatal skeletal development and postnatal bone remodeling and confirmed their essential roles in osteogenesis, bone formation, and bone mineral density (BMD) determination. © 2011 American Society for Bone and Mineral Research. Copyright © 2011 American Society for Bone and Mineral Research.
dc.description.natureLink_to_subscribed_fulltext
dc.identifier.citationJournal Of Bone And Mineral Research, 2011, v. 26 n. 3, p. 582-590 [How to Cite?]
DOI: http://dx.doi.org/10.1002/jbmr.240
dc.identifier.doihttp://dx.doi.org/10.1002/jbmr.240
dc.identifier.epage590
dc.identifier.hkuros184858
dc.identifier.isiWOS:000287827600019
Funding AgencyGrant Number
KC Wong Education Foundation
Osteoporosis and Endocrine Research, the University of Hong Kong
Funding Information:

ZD was supported by the KC Wong Education Foundation. This project was supported by the Osteoporosis and Endocrine Research, the University of Hong Kong.

dc.identifier.issn0884-0431
2011 Impact Factor: 6.373
2011 SCImago Journal Rankings: 0.622
dc.identifier.issue3
dc.identifier.openurl
dc.identifier.pmid20818642
dc.identifier.scopuseid_2-s2.0-79951842355
dc.identifier.spage582
dc.identifier.urihttp://hdl.handle.net/10722/133316
dc.identifier.volume26
dc.languageeng
dc.publisherAmerican Society for Bone and Mineral Research. The Journal's web site is located at http://www.jbmr.org/view/0/index.html
dc.publisher.placeUnited States
dc.relation.ispartofJournal of Bone and Mineral Research
dc.relation.referencesReferences in Scopus
dc.subject.meshAging - metabolism
dc.subject.meshAnimals
dc.subject.meshBone and Bones - embryology - pathology
dc.subject.meshCell Count
dc.subject.meshCell Differentiation
dc.subject.meshCell Line
dc.subject.meshEmbryo, Mammalian - metabolism
dc.subject.meshGene Deletion
dc.subject.meshInositol - metabolism
dc.subject.meshInositol 1,4,5-Trisphosphate - metabolism
dc.subject.meshIntracellular Space - metabolism
dc.subject.meshMesenchymal Stem Cells - cytology - metabolism
dc.subject.meshMice
dc.subject.meshOrgan Size
dc.subject.meshOsteoblasts - metabolism - pathology
dc.subject.meshOsteogenesis
dc.subject.meshOsteoporosis - metabolism - pathology
dc.subject.meshSymporters - deficiency - metabolism
dc.subject.meshTranscription, Genetic
dc.subjectbone formation
dc.subjectmyo-inositol
dc.subjectosteogenesis
dc.subjectSmit1
dc.titleSodium/myo-inositol cotransporter 1 and myo-inositol are essential for osteogenesis and bone formation
dc.typeArticle
Author Affiliations
  1. The University of Hong Kong
  2. Nanjing Medical University